Target intelligence / Profile preview

Bacterial ribosome A-site RNA (none)

Target
none
Molecular classification
Ribosomal RNA, Non-coding RNA, Component of ribosome, Other
01

Overview

Bacterial ribosome A-site RNA refers to a highly conserved region within the 16S ribosomal RNA (rRNA) of the small (30S) subunit of the bacterial ribosome that serves as the aminoacyl-tRNA (A) binding site. This site is critical for ensuring the accuracy (fidelity) of translation by facilitating correct codon-anticodon pairing between mRNA and incoming aminoacyl-tRNA[2][6]. The A-site's structure features bulged nucleotides (notably A1492 and A1493 in E. coli numbering) that flip out to inspect codon-anticodon pairing, switching between 'off' and 'on' conformational states to regulate translation[2]. The A-site is a prominent target for several classes of antibiotics—including aminoglycosides and tetracyclines—which bind specifically to this RNA pocket, disrupting normal translation, promoting miscoding, or preventing tRNA binding[4][5][6]. The essential function and unique structural features of the bacterial A-site make it one of the most validated and exploited targets for antibacterial drug development, although conserved elements in eukaryotic and mitochondrial ribosomes present safety concerns regarding off-target effects and toxicity[4][5][6].

Other names
Ribosomal A-site RNADecoding center A-site RNA16S rRNA A-siteAminoacyl-tRNA acceptor site
02

Mechanism of action

Inhibition of protein synthesis via binding to the A-site and disruption of decoding (aminoglycosides promote misreading or block translocation) Blockage of tRNA binding (tetracyclines prevent aminoacyl-tRNA from accessing the A-site)

03

Biological functions

Decoding center for mRNA translationFidelity control in codon-anticodon pairingMediates tRNA and release factor binding during translationEssential for protein synthesis
04

Disease associations

Infection (as a target in bacteria)Other
05

Safety considerations

Selectivity for bacterial over human ribosome A-site (mitochondrial ribosomes can be affected, leading to toxicity)Potential for resistance through mutation or methylation of the A-site RNA
06

Interacting drugs

Aminoglycoside antibiotics (e.g., paromomycin, gentamicin, streptomycin)

2 more in the full profile.

Beyond the preview

Go deeper on Bacterial ribosome A-site RNA (none).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial ribosome A-site RNA (none).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call